The following material has been sourced from the Australian Institute of Health and Welfare
Gynaecological cancers incorporates ICD-10 cancer codes C51 (Malignant neoplasm of vulva), C52 (Malignant neoplasm of vagina), C53 (Malignant neoplasm of cervix), C54 (Malignant neoplasm of corpus uteri), C55 (Malignant neoplasm of uterus, part unspecified), C56 (Malignant neoplasm of ovary), C57 (Malignant neoplasm of other and unspecified female genital organs) and C58 (Malignant neoplasm of placenta).
New cases
In 2021, there were 6,520 new cases of gynaecological cancers diagnosed in Australia. In 2025, it is estimated that 7,047 new cases of gynaecological cancers will be diagnosed in Australia. In 2025, it is estimated that a female has a 1 in 23 (or 4.3%) risk of being diagnosed with a gynaecological cancer by the age of 85.
Graph: statistics-gynaecological-cancers-figure-1-estimated-cancer-incidence-2025
In 2021, the age-standardised incidence rate was 49 cases per 100,000 females. In 2025, it is estimated that the age-standardised incidence rate will be 49 cases per 100,000 females. The incidence rate for gynaecological cancers is expected to increase with age, up to 80–84 years.
Graph: statistics-gynaecological-cancers-figure-2-age-standardised-incidence-rates-2025
The number of new cases of gynaecological cancers diagnosed increased from 2,955 in 1982 to 6,520 in 2021. Over the same period, the age-standardised incidence rate decreased from 51 cases per 100,000 females in 1982 to 49 cases per 100,000 females in 2021.
Deaths
In 2023, there were 2,204 deaths from gynaecological cancers in Australia. In 2025, it is estimated that there will be 2,300 deaths. In 2025, it is estimated that a female has a 1 in 73 (or 1.4%) risk of dying from a gynaecological cancer by the age of 85.
Graph: statistics-gynaecological-cancers-figure-3-estimated-cancer-mortality-2025
In 2023, the age-standardised mortality rate was 16 deaths per 100,000 females. In 2025, it is estimated that the age-standardised mortality rate will be 16 deaths per 100,000 females. The mortality rate for gynaecological cancers is expected to increase with age.
Graph: statistics-gynaecological-cancers-figure-4-age-standardised-mortality-rates-2025
The number of deaths from gynaecological cancers increased from 1,235 in 1982 to 2,204 in 2023. Over the same period, the age-standardised mortality rate decreased from 23 deaths per 100,000 females in 1982 to 16 deaths per 100,000 females in 2023.
Survival
In 2017–2021, individuals diagnosed with gynaecological cancers had a 71% chance of surviving for five years compared to their counterparts in the general Australian population. Between 1987–1991 and 2017–2021, five-year relative survival for gynaecological cancers improved from 63% to 71%.
Graph: statistics-gynaecological-cancers-figure-5-5-year-relative-survival-2025
Prevalence
At the end of 2021, there were 5,905 people living who had been diagnosed with gynaecological cancers that year, 23,957 people living who had been diagnosed with gynaecological cancers in the previous 5 years (from 2017 to 2021) and 78,497 people living who had been diagnosed with gynaecological cancers in the previous 40 years (from 1982 to 2021).
For more information, see Gynaecological cancers on the NCCI website
The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes. The NCCI website allows users to see visual representations of data on each indicator through interactive charts.
